Ronald G. Browne - Concepedia

Author

Ronald G. Browne

Pfizer (United States)

Also Known As

R Browne, R G Browne, R. G. BROWNE, R. G. Browne, R.G. Browne, RONALD BROWNE, RONALD G. BROWNE, Ronald G. Browne

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)University of California San Diego University of California, Irvine The University of Texas Health Science Center at Houston Texas Research Institute

About

Ronald G. Browne is an author at Pfizer (United States) specializing in medicine, neuropharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	14	559
2	Social Sciences	9	9	439
3	Health Sciences	3	3	78
4	Behavioral Sciences	2	2	96
5	Education	1	1	11

Ronald G. Browne

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants Reinhard Sarges, Harry Howard, Ronald G. Browne, Journal of Medicinal Chemistry	1990	407
Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. B. Kenneth Koe, Arthur D. Weissman, W. M. WELCH, Journal of Pharmacology and Experimental Therapeutics	1983	257
Analog Classroom Assessment of Adderall® in Children With ADHD James M. Swanson, Sharon B. Wigal, Laurence L. Greenhill, Journal of the American Academy of Child & Adolescent Psychiatry	1998	218
A Double-Blind, Placebo-Controlled Study of Adderall and Methylphenidate in the Treatment of Attention-Deficit/Hyperactivity Disorder Steven R. Pliszka, Ronald G. Browne, Rene L. Olvera, Journal of the American Academy of Child & Adolescent Psychiatry AdhdNeuropsychologyPsychoactive DrugPsychiatryMedicine	2000	132
Effects of antidepressants and anticholinergics in a mouse “behavioral despair” test Ronald G. Browne European Journal of Pharmacology PsychiatryMood SymptomPsychotropic MedicationBehavioral PharmacologyDepression	1979	86
Metabolic and experiential factors in the behavioral response to repeated amphetamine Ronald G. Browne, David S. Segal Pharmacology Biochemistry and Behavior Substance AbuseBehavioral SciencesPsychoactive DrugBehavioral NeuroscienceAddiction	1977	85
Stereoselective Antagonism of Phencyclidine's Discriminative Properties by Adenosine Receptor Agonists Ronald G. Browne, Willard M. Welch Science	1982	68
Role of serotonin in the discriminative stimulus properties of mescaline Ronald G. Browne, Beng T. Ho Pharmacology Biochemistry and Behavior Neurobiological MechanismDiscriminative Stimulus PropertiesBehavioral NeuroscienceNeuroanatomyNeurophysiology	1975	50
Comparison of opiate- and opioid-peptide-induced immobility Ronald G. Browne, David C. Derrington, David S. Segal Life Sciences Opioid-peptide-induced ImmobilityAddictionMedicineNeuropharmacologyAddiction Medicine	1979	48
Bradykinin antagonism: differentiation between peptide antagonists and antiinflammatory agents Nour‐Eddine Rhaleb, Stéphane Dion, Pedro D’Orléans-Juste, European Journal of Pharmacology InflammationMedicinePharmacotherapyNon-peptide LigandPharmacology	1988	34

Page 1